Clinical Hospital Merkur

Zagreb 10000

1 studies enrolling now · 6 studies all time

What they study most

B-Cell Chronic Lymphocytic Leukemia, Colitis, Ulcerative, Crohn Disease, Immunoglobulin A Nephropathy, MDS, MF, Myelodysplastic Syndrome, Myelofibrosis, Post-ET Myelofibrosis, Post-PV MF, Primary Myelofibrosis, RAEB

Studies at this site

• Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib — Recruiting now
• Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN) — Running, not enrolling
• Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA — Stopped early
• An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis — Completed
• Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease — Stopped early
• Fludarabine (Fludara®) Plus Alemtuzumab (CAMPATH®, MabCampath®) vs Fludarabine Alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients — Completed